Obesity
Showing NaN - NaN of 101
Overweight, Obesity Trial in Rochester (Deaf Weight Wise 2.0)
Completed
- Overweight
- Obesity
- Deaf Weight Wise 2.0
-
Rochester, New YorkUniversity of Rochester; National Center for Deaf Health Researc
Oct 17, 2019
Cardiovascular Disease, High Cardiovascular Risk, Obesity Trial in Worldwide (Lorcaserin HCl, Placebo)
Completed
- Cardiovascular Disease
- +4 more
- Lorcaserin hydrochloride
- Placebo
-
Alexander City, Alabama
- +498 more
Jun 27, 2019
Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma, Fatigue Trial in Korea, Republic of, United States
Unknown status
- Endometrial Clear Cell Adenocarcinoma
- +6 more
- 3-Dimensional Conformal Radiation Therapy
- +7 more
-
Birmingham, Alabama
- +539 more
Mar 8, 2019
Obesity Trial in Rochester (overfeeding induced weight gain)
Completed
- Obesity
- overfeeding induced weight gain
-
Rochester, Minnesota
- +1 more
Jan 8, 2019
Obesity Trial in Rochester (InSciEd Out Fitness and Nutrition Curriculum)
Withdrawn
- Obesity
- InSciEd Out Fitness and Nutrition Curriculum
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 2, 2019
Overweight, Obesity Trial in Rochester (Deaf Weight Wise program)
Completed
- Overweight
- Obesity
- Deaf Weight Wise program
-
Rochester, New YorkUniversity of Rochester; National Center for Deaf Health Researc
May 17, 2018
Obesity Trial in United States (S-2367 Placebo, S-2367 800 mg, S-2367 1600 mg)
Completed
- Obesity
- S-2367 Placebo
- +3 more
-
Mobile, Alabama
- +37 more
May 8, 2018
Obesity Trial in United States (Velneperit 400 mg, Orlistat 120 mg, Orlistat Placebo)
Completed
- Obesity
- Velneperit 400 mg
- +4 more
-
Santa Rosa, California
- +24 more
May 7, 2018
Obesity Trial in United States (S-2367 (velneperit))
Completed
- Obesity
- S-2367 (velneperit)
-
Birmingham, Alabama
- +72 more
Apr 26, 2018
Obesity, Pre-Renal Transplant Candidate, Pre-liver Transplant Candidate Trial in Rochester (Use of smartphone app)
Withdrawn
- Obesity
- +2 more
- Use of smartphone app
-
Rochester, MinnesotaMayo Clinic in Rochester
Mar 20, 2018
Obesity, Liver Cirrhosis Trial in Rochester (ORBERA Intragastric Balloon)
Terminated
- Obesity
- Liver Cirrhosis
- ORBERA Intragastric Balloon
-
Rochester, MinnesotaMayo Clinic
Jan 4, 2018
Metabolism and Nutrition Disorder, Obesity Trial in Worldwide (liraglutide, )
Completed
- Metabolism and Nutrition Disorder
- Obesity
- liraglutide
- placebo
-
Birmingham, Alabama
- +225 more
Dec 20, 2017
Obesity Trial in Rochester (Liraglutide, Placebo)
Obesity Trial in Australia, United States (vBloc (Active Device), Sham (Non-active Device))
Unknown status
- Obesity
- vBloc (Active Device)
- Sham (Non-active Device)
-
Scottsdale, Arizona
- +9 more
Aug 1, 2017
Type 2 Diabetes, Obesity Trial in United States (EndoBarrier, Sham Procedure)
Terminated
- Type 2 Diabetes
- Obesity
- EndoBarrier
- Sham Procedure
-
Birmingham, Alabama
- +24 more
Dec 2, 2016
Obesity Trial in Rochester (obesity)
Completed
- Obesity
- obesity
-
Rochester, MinnesotaMayo Clinic
Nov 8, 2016
Obesity, Type II Diabetes, Cardiovascular Disease Trial in Rochester (STRIDES, Sham Control)
Completed
- Obesity
- +3 more
- STRIDES
- Sham Control
-
Rochester, New YorkUniversity of Rochester
Apr 29, 2015
FFA Metabolism in Different Types of Human Obesity
Withdrawn
- Obesity
-
Rochester, MinnesotaMayo Clinic
Apr 29, 2015
Obesity Trial in Rochester (Botulinum toxin, Overstitch Endoscopic Suturing System)
Completed
- Obesity
- Botulinum toxin
- Overstitch Endoscopic Suturing System
-
Rochester, MinnesotaMayo Foundation
Apr 6, 2015
Obesity Trial in Rochester (Telecoaching plus Plate, Usual Care)
Completed
- Obesity
- Telecoaching plus Plate
- Usual Care
-
Rochester, MinnesotaMayo Clinic
Feb 26, 2015